MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer

Pancreatic cancer has a poor prognosis due to late diagnosis and ineffective therapeutic multimodality. MUC13, a transmembrane mucin is highly involved in pancreatic cancer progression. Thus, understanding its regulatory molecular mechanisms may offer new avenue of therapy for prevention/treatment of pancreatic cancer. Herein, we report a novel microRNA (miR-145)-mediated mechanism regulating aberrant MUC13 expression in pancreatic cancer. We report that miR-145 expression inversely correlates with MUC13 expression in pancreatic cancer cells and human tumor tissues. miR-145 is predominantly present in normal pancreatic tissues and early Pancreatic Ductal Adenocarcinoma (PDAC) precursor lesions (PanIN I) and is progressively suppressed over the course of development from PanIN II/III to late stage poorly differentiated PDAC. We demonstrate that miR-145 targets 3′ untranslated region of MUC13 and thus downregulates MUC13 protein expression in cells. Interestingly, transfection of miR-145 inhibits cell proliferation, invasion and enhances gemcitabine sensitivity. It causes reduction of HER2, P-AKT, PAK1 and an increase in p53. Similar results were found when MUC13 was specifically inhibited by shRNA directed at MUC13. Additionally, intratumoral injections of miR-145 in xenograft mice inhibited tumor growth via suppression of MUC13 and its downstream target, HER2. These results suggest miR-145 as a novel regulator of MUC13 in pancreatic cancer.

[1]  A. Goswami,et al.  A Novel MMP-2 Inhibitor 3-azidowithaferin A (3-azidoWA) Abrogates Cancer Cell Invasion and Angiogenesis by Modulating Extracellular Par-4 , 2012, PloS one.

[2]  Deepak Kumar,et al.  Mucins in ovarian cancer diagnosis and therapy , 2009, Journal of ovarian research.

[3]  S. Jain,et al.  A cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic death. , 2011, European journal of pharmacology.

[4]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[5]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[6]  Tianyuan Xu,et al.  MicroRNA‐145 directly targets the insulin‐like growth factor receptor I in human bladder cancer cells , 2014, FEBS letters.

[7]  H. Aburatani,et al.  MUC13 Mucin Augments Pancreatic Tumorigenesis , 2011, Molecular Cancer Therapeutics.

[8]  H. Aburatani,et al.  Expression and functions of transmembrane mucin MUC13 in ovarian cancer. , 2009, Cancer research.

[9]  S. Goodman,et al.  Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. , 1996, Human pathology.

[10]  Q. Yao,et al.  Overcoming drug resistance in pancreatic cancer , 2011, Expert opinion on therapeutic targets.

[11]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[12]  M. Mimeault,et al.  Recent Advances on the Molecular Mechanisms Involved in Pancreatic Cancer Progression and Therapies , 2005, Pancreas.

[13]  N. Smorodinsky,et al.  The MUC1 oncoprotein as a functional target: Immunotoxin binding to α/β junction mediates cell killing , 2009, International journal of cancer.

[14]  S. Khan,et al.  Targeting Micrornas in Pancreatic Cancer: Microplayers in the Big Game Pancreatic Cancer and Mirna , 2022 .

[15]  Guang-Yuh Chiou,et al.  miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. , 2013, Cancer research.

[16]  Huazong Zeng,et al.  miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc , 2010, Journal of experimental & clinical cancer research : CR.

[17]  Y. Mo,et al.  MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. , 2010, Cancer research.

[18]  C. Bracken,et al.  Experimental strategies for microRNA target identification , 2011, Nucleic acids research.

[19]  E. Fishman,et al.  Recent progress in pancreatic cancer , 2013, CA: a cancer journal for clinicians.

[20]  V. Kim,et al.  Biogenesis of small RNAs in animals , 2009, Nature Reviews Molecular Cell Biology.

[21]  P. Rao,et al.  E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. , 2005, Cancer research.

[22]  T. Davison,et al.  MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma , 2007, Oncogene.

[23]  A. Maitra,et al.  Pancreatic Carcinogenesis , 2008, Pancreatology.

[24]  M. Merino,et al.  miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3. , 2014, Endocrine-related cancer.

[25]  A. Krogh,et al.  MicroRNA-145 Targets YES and STAT1 in Colon Cancer Cells , 2010, PloS one.

[26]  Shadi F Othman,et al.  Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications , 2012, International journal of nanomedicine.

[27]  S. Jain,et al.  A Novel cyano derivative of 11‐Keto‐β‐Boswellic acid causes apoptotic death by disrupting PI3K/AKT/Hsp‐90 cascade, mitochondrial integrity, and other cell survival signaling events in HL‐60 cells , 2012, Molecular carcinogenesis.

[28]  R. Dahiya,et al.  MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. , 2011, Cancer research.

[29]  Ravibhushan Singh,et al.  MUC1: A target molecule for cancer therapy , 2007, Cancer biology & therapy.

[30]  Thomas D. Schmittgen,et al.  Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.

[31]  D. Kufe,et al.  Mucins in cancer: function, prognosis and therapy , 2009, Nature Reviews Cancer.

[32]  G. Pan,et al.  MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.

[33]  Wen Li,et al.  miR‐145 suppresses cell invasion in hepatocellular carcinoma cells: miR‐145 targets ADAM17 , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[34]  Wendy Frankel,et al.  MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival , 2008, Journal of Gastrointestinal Surgery.

[35]  Qing Xu,et al.  MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis , 2011, Nucleic acids research.